当前位置:首页 - 行情中心 - 鱼跃医疗(002223) - 财务分析

鱼跃医疗

(002223)

  

流通市值:331.78亿  总市值:353.77亿
流通股本:9.40亿   总股本:10.02亿

鱼跃医疗(002223)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润14.66亿元,每股收益1.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1363520.48万元,未分配利润1008045.32万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1667124.11万元,负债303603.63万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入6,544,895,742.684,658,967,431.032,435,873,177.347,565,819,017.28
营业总成本5,187,824,391.823,579,183,683.091,816,105,564.515,947,065,140.88
其他经营收益
营业利润1,685,030,326.081,386,867,012.99736,901,006.131,931,581,058.87
利润总额1,684,332,877.451,387,100,427.73737,099,415.221,932,828,551.12
净利润1,466,298,649.791,199,667,055.45623,182,616.761,804,266,349.2
每股收益
其他综合收益-25,254,882.74-42,485,052.57-53,795,499.78157,085,418.17
综合收益总额1,441,043,767.051,157,182,002.88569,387,116.981,961,351,767.37
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计10,223,791,620.8510,064,100,218.059,938,453,882.59,258,791,831.87
非流动资产:
非流动资产合计6,447,449,482.286,464,655,748.276,477,922,869.326,386,990,667.17
资产总计16,671,241,103.1316,528,755,966.3216,416,376,751.8215,645,782,499.04
流动负债:
流动负债合计2,768,309,795.862,834,995,169.992,900,863,483.462,692,829,817.68
非流动负债:
非流动负债合计267,726,475.98273,556,915.68288,409,640.59298,773,832.19
负债合计3,036,036,271.843,108,552,085.673,189,273,124.052,991,603,649.87
所有者权益(或股东权益):
归属于母公司股东权益合计13,521,175,567.8113,300,486,530.7113,106,925,442.9512,535,332,607.69
股东权益合计13,635,204,831.2913,420,203,880.6513,227,103,627.7712,654,178,849.17
负债和股东权益合计16,671,241,103.1316,528,755,966.3216,416,376,751.8215,645,782,499.04
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计7,146,382,148.934,827,739,978.242,358,650,181.128,490,417,004.69
经营活动现金流出小计5,642,881,477.483,660,879,300.91,700,935,666.036,674,147,271.92
经营活动产生的现金流量净额1,503,500,671.451,166,860,677.34657,714,515.091,816,269,732.77
投资活动产生的现金流量:
投资活动现金流入小计140,748,706.07117,727,897.8137,746,194.75299,721,269.75
投资活动现金流出小计373,222,771.81258,166,461.59232,850,986.45325,219,860.86
投资活动产生的现金流量净额-232,474,065.74-140,438,563.78-195,104,791.7-25,498,591.11
筹资活动产生的现金流量:
筹资活动现金流入小计9,701,657.19,701,657.12,500,00035,182,117.06
筹资活动现金流出小计412,423,212.99406,943,868.747,201,657.12,434,342,246.45
筹资活动产生的现金流量净额-402,721,555.89-397,242,211.64-4,701,657.1-2,399,160,129.39
汇率变动对现金及现金等价物的影响-21,220,102.32-12,673,315.72-1,663,513.5216,535,824.88
现金及现金等价物净增加额847,084,947.5616,506,586.2456,244,552.77-591,853,162.85
期末现金及现金等价物余额7,443,083,356.427,212,504,995.127,072,393,190.466,595,998,408.92
补充资料:
现金及现金等价物的净增加额-616,506,586.2--591,853,162.85
最新报告期:2025-10-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华源证券刘闯1.822.162.542025-10-28
野村东方国际证券孔令岩2.012.322.572025-10-28
兴业证券孙媛媛,董晓洁1.962.262.612025-10-28
平安证券叶寅,倪亦道,裴晓鹏1.912.262.662025-10-28
西南证券杜向阳1.852.152.562025-10-27
TOP↑